Coldrex Lariplus

Coldrex LariPlus: description of the drug and its use

Coldrex LariPlus is a local anesthetic used to treat inflammatory diseases of the oral cavity, pharynx and larynx. It contains the active substance Dyclonine, which has a local analgesic effect.

The drug is manufactured by Smithkline Beecham in the United States of America and is available in two forms: lozenges in three flavors (cherry, orange, lemon) in blisters and cherry flavored lollipops in blisters.

Coldrex LariPlus is contraindicated for children under 12 years of age and persons with hypersensitivity to its components. Some side effects may occur with use, such as oral irritation, changes in taste, dyspeptic symptoms and allergic reactions such as skin rashes and anaphylaxis.

It must be remembered that with severe damage to the mucous membrane of the throat and oral cavity, the likelihood of systemic reactions increases, therefore the use of Coldrex LariPlus should be discussed with a doctor.

There is no data on interactions with other drugs and on overdose of Coldrex LariPlus in the literature. However, before using the drug, you should consult your doctor or pharmacist for detailed information about its use and possible side effects.

Thus, Coldrex LariPlus is an effective local anesthetic for the treatment of inflammatory diseases of the oral cavity, pharynx and larynx, but its use must be discussed with a doctor and carried out in accordance with the instructions for use.